Skip to content
Boost Up Blog – Lifestyle
Author:
Blood Cancer United® formerly The Leukemia & Lymphoma Society
Beat AML® Study Provides New Data on 14-Day vs. 28-Day Venetoclax-Azacitidine Treatment in AML
July 30, 2026
Blood Cancer United Acquires Investigational Drug Supply to Preserve Access for Children with Rare, Fatal Leukemia
June 11, 2026